Fatty liver disease (MASLD/MASH) trials in China

In China 73 Also abroad 367

73 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Where
Beijing
Age
18 years to 75 years
People
156
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07145151
Phase 3Not yet taking people in China
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Where
Chengdu, Luoyang, Nanjing, Shanghai
Age
18 years and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00
Phase 3Taking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Beijing, Changchun, Changsha, Changzhou Shi, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Guiyang, Hangzhou, Jiaxing, Liaocheng, Luoyang, Nanchang, Nanjing, Ningbo, Ningxia, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Suzhou, Tianjin, Wenzhou, Wuhan, Wuxi, Xi'an, Xuzhou, Yanji, Yueyang, Yuncheng, Zhengzhou, Zhenjiang
Age
18 years and over
People
1,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
Phase 3Taking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Beijing, Changchun, Changsha, Changzhou Shi, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Jiaxing, Kunming, Liaocheng, Luoyang, Nanchang, Nanjing, Ningbo, Ningxia, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Suzhou, Tianjin, Wenzhou, Wuhan, Xi'an, Zhengzhou, Zhenjiang
Age
18 years and over
People
1,590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
Phase 1/2Taking people
High-Plant-Protein-Diet or High-Animal-Protein-Diet for Improving Alcoholic Fatty Liver Disease
Where
Hangzhou
Age
18 years to 74 years
People
74
Run by
Li Lab,MD
See details and how to joinNCT07897981
No phaseTaking people
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
Where
Beijing
Age
18 years to 65 years
People
216
Run by
Liu Yan
See details and how to joinNCT07237750
No phaseNot yet taking people in China
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
Where
Taiyuan
Age
18 years to 79 years
People
25,974
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07884903
Phase 2Not yet taking people in China
A Phase 2a Study of Kylo-0603 Capsule in Participants With Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Where
Beijing
Age
18 years to 70 years
People
120
Run by
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07878091
Phase 3Taking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Guiyang, Hangzhou, Jinhua, Liaocheng, Luoyang, Luzhou, Nanchang, Nanjing, Nanyang, Ningbo, Pingxiang, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Xi’an, Yinchuan, Zhoukou
Age
18 years and over
People
4,500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
Phase 3Taking people
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
Where
Beijing
Age
18 years and over
People
886
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07581951
Phase 4Taking people
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
Where
Beijing, Chengdu, Chongqing, Hefei
Age
18 years to 60 years
People
60
Run by
West China Hospital
See details and how to joinNCT07718126
Phase 1Taking people
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
Where
Chengdu
Age
18 years to 65 years
People
32
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07807059
No phaseTaking people
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
Where
Beijing
Age
18 years to 70 years
People
500
Run by
Beijing Friendship Hospital
See details and how to joinNCT03635541
Phase 1Not yet taking people in China
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)
Where
Beijing, Shanghai, Xiamen, Xi’an
Age
18 years to 69 years
People
24
Run by
Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT07462455
Phase 1Taking people
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Where
Kunming
Age
18 years to 50 years
People
36
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809
Phase 2Taking people
A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis
Where
Beijing, Zhengzhou
Age
18 years to 75 years
People
160
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07660848
No phaseNot yet taking people in China
Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
Where
Putian
Age
30 years to 60 years
People
84
Run by
The 95th Hospital of Putian，Putian, Fujian, China
See details and how to joinNCT07778719
No phaseTaking people
Digital Early Warning System for Acute Lung Injury in Liver Surgery
Where
Beijing, Chongqing, Qingdao
Age
18 years and over
People
3,000
Run by
Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT07070362
No phaseTaking people
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Where
Hong Kong
People
1,500
Run by
Humanity and Health Research Centre
See details and how to joinNCT02863757
No phaseTaking people
Nonalcoholic Steatohepatitis in Chinese Children
Where
Beijing
Age
1 year to 18 years
People
400
Run by
Humanity and Health Research Centre
See details and how to joinNCT03190538
No phaseNot yet taking people in China
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
Where
Hanzhou
Age
18 years and over
People
7,000
Run by
The Affiliated Hospital of Hangzhou Normal University
See details and how to joinNCT07706010
Phase 3Not yet taking people in China
A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
Where
Shanghai
Age
18 years and over
People
480
Run by
Zhejiang Doer Biologics Co., Ltd.
See details and how to joinNCT07693777
No phaseTaking people
Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Where
Beijing
Age
18 years and over
People
470
Run by
Novo Nordisk A/S
See details and how to joinNCT07682363
Phase 1/2Taking people
Dihydroartemisinin for MAFLD
Where
Nanjing
Age
18 years to 45 years
People
30
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07679542
No phaseNot yet taking people in China
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV
Where
Shanghai
Age
18 years to 80 years
People
120
Run by
Yinzhong Shen
See details and how to joinNCT07640880